Shah Nikita

Executive Vice PresidentAmneal Pharmaceuticals, Inc. (AMRX) · full profile →Form 4 · filed Aug 25, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.2M
Net Open-Market Flow
-$1.2M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 25, 2025Sell(S)6K$9.50$60K146K
Aug 22, 2025Sell(S)114K$9.66$1.1M153K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001738061-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.